1 of 1
Story summary
- Singapore's Deputy Prime Minister Gan Kim Yong warned that Trump's 100% tariffs on pharmaceuticals could shift investment patterns away from Singapore.
- Pharmaceutical exports to the U.S. total $4 billion, representing 13% of Singapore's domestic exports to the U.S.
- The government is clarifying tariff-exemption eligibility for U.S. manufacturing investments.
- Singapore seeks a tariff cap like U.S. deals with Japan and EU.
